Overview
Keytruda Qlex is approved by the U.S. Food and Drug Administration (FDA) for several types of non-small cell lung cancer (NSCLC). It is approved in combination with pemetrexed and a platinum-based chemotherapy…
Overview
Keytruda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic small cell lung cancer and various non-small cell lung cancers. Keytruda is also referred to by its… read more